EUVIMEDEUVIMED entdecken
Open Access

A unique inflammaging profile generated by T cells from people with obesity is metformin resistant

S SantaCruz-Calvo iD, S Saraswat, G H Kalantar, E Zukowski, H Marszalkowski, A Javidan, F Gholamrezaeinejad, L P Bharath, P A Kern, X D Zhang, B S Nikolajczyk iD

GeroScience · 21.12.2024 · 47 (3) · 3725-3739

DOI: 10.1007/s11357-024-01441-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GeroScience, online erschienen am 21.12.2024. Verfasst von S SantaCruz-Calvo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Nutritional Sciences, Diabetes and Obesity Research Priority Area, University of Kentucky, Lexington, KY, USA. Hauptthemen laut MEDLINE: Metformin, Obesity, Inflammation, Aging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Basic Research Laboratory, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The alarmingly high prevalence of obesity in older adults coupled with the negative health effects of chronic inflammation in both obesity and aging highlight the importance of studies investigating the impacts of obesity on age-related inflammation. Since shifts in peripheral T-cell metabolism and function drive systemic inflammation in both obesity and aging, we hypothesize that obesity impacts the Th17-dominated inflammaging profile we identified in lean subjects and thus modifies the anti-inflammatory effects of geroprotective drugs like metformin. New cytokine profiling data showed that CD4+ T cells from older people with obesity generate a profile that specifically excludes Th17 cytokines. Metformin failed to change the age-associated T-cell profile in obesity, despite lowering both mitochondrial respiration and reactive oxygen species (ROS) production. Metformin did not improve macroautophagy in T cells from older people with obesity, in sharp contrast to the ability of metformin to promote autophagy in T cells from older lean subjects. These data indicate that body mass index modifies the mechanisms supporting inflammaging in T cells from older subjects, and that metformin-mediated restoration of redox balance is insufficient to stem obesity-associated inflammaging. We conclude that obesity fundamentally changes the mechanisms that promote inflammaging, and thus obesity becomes a critical consideration for clinical trials of geroprotective agents such as metformin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminObesityInflammationAgingHypoglycemic AgentsT-LymphocytesHumansAgedMaleFemaleMiddle AgedTh17 CellsCytokinesAutophagyReactive Oxygen SpeciesBody Mass IndexCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

Age-related inflammationAutophagyPartial least squares discriminant analysisRedox balanceSystemic inflammation

Substanzen

MetforminCytokinesHypoglycemic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pharmacology & Nutritional Sciences, Diabetes and Obesity Research Priority Area, University of Kentucky, Lexington, KY, USA.
  • Department of Biostatistics, University of Kentucky, Lexington, KY, USA.
  • Department of Microbiology, Immunology & Molecular Genetics, University of Kentucky, Lexington, KY, USA.
  • Department of Nutrition & Public Health, Merrimack College, North Andover, MA, USA.
  • Department of Biology, Merrimack College, North Andover, MA, USA.
  • Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.

ORCID-Profile: S SantaCruz-Calvo, B S Nikolajczyk

Förderung

  • NIGMS NIH HHS
  • Basic Research Laboratory
  • NIA NIH HHS
  • Division of Diabetes, Endocrinology, and Metabolic Diseases
  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NCI NIH HHS
  • National Institute on Aging

Zitieren

APA

SantaCruz-Calvo, S., Saraswat, S., Kalantar, G. H., Zukowski, E., Marszalkowski, H., Javidan, A., Gholamrezaeinejad, F., Bharath, L. P., Kern, P. A., Zhang, X. D., & Nikolajczyk, B. S. (2024). A unique inflammaging profile generated by T cells from people with obesity is metformin resistant. GeroScience, 47(3), 3725-3739. https://doi.org/10.1007/s11357-024-01441-4

Vancouver

SantaCruz-Calvo S, Saraswat S, Kalantar GH, Zukowski E, Marszalkowski H, Javidan A, et al. A unique inflammaging profile generated by T cells from people with obesity is metformin resistant. GeroScience. 2024;47(3):3725-3739. doi:10.1007/s11357-024-01441-4

BibTeX
@article{SantaCruzCalvo2024,
  author = {SantaCruz-Calvo, S and Saraswat, S and Kalantar, G H and Zukowski, E and Marszalkowski, H and Javidan, A and Gholamrezaeinejad, F and Bharath, L P and Kern, P A and Zhang, X D and Nikolajczyk, B S},
  title = {A unique inflammaging profile generated by T cells from people with obesity is metformin resistant},
  journal = {GeroScience},
  year = {2024},
  volume = {47},
  number = {3},
  pages = {3725--3739},
  doi = {10.1007/s11357-024-01441-4}
}
Kostenlos starten →